Gene expression-based prediction of myeloma cell sensitivity to histone deacetylase inhibitors

BACKGROUND: Multiple myeloma (MM) is still a fatal plasma cell cancer. Novel compounds are currently clinically tested as a single agent in relapsing patients, but in best cases with partial response of a fraction of patients, emphasising the need to design tools predicting drug efficacy. Histone de...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Moreaux, J, Reme, T, Leonard, W, Veyrune, J-L, Requirand, G, Goldschmidt, H, Hose, D, Klein, B
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2013
Assuntos:
Translational Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3739014/
https://ncbi.nlm.nih.gov/pubmed/23868005
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2013.392
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados